Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
International Immunopharmacology|July 6, 2023
Suppression of TLR4 prevents diabetic bone loss by regulating FTO-mediated m<sup>6</sup>A modificationXimei Shen, Chao Lan, Youfen Lin, et al.
Metabolism: Clinical and Experimental|December 24, 2013
The effect of FFAR1 on pioglitazone-mediated attenuation of palmitic acid-induced oxidative stress and apoptosis in βTC6 cellsXimei Shen, Liyong Yang, Sunjie Yan, et al.
Frontiers in Endocrinology|June 14, 2024
Association of high vibration perception threshold with reduced renal function in patients with type 2 diabetesYongze Zhang, Biao Zheng, Yimei Li, et al.
Molecular Immunology|November 16, 2019
Toll-like receptor 4 knockout protects against diabetic-induced imbalance of bone metabolism via autophagic suppressionYongze Zhang, Ximei Shen, Ling Cheng, et al.
Kidney & Blood Pressure Research|August 24, 2021
Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 DiabetesXinyu Hong, Lingning Huang, Yongze Zhang, et al.
Endocrine|January 22, 2022
Association of decreased muscle mass with reduced bone mineral density in patients with Graves' diseaseYongze Zhang, Yuzhen Ke, Lingning Huang, et al.
Acta Biochimica Et Biophysica Sinica|April 2, 2025
TLR4 mediates lipotoxic β-cell dysfunction by inhibiting the TMEM24/PI3K/AKT pathwayChao Lan, Yan Li, Zhiyan Weng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2022
Activation of osteoblast ferroptosis via the METTL3/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone lossYoufen Lin, Ximei Shen, Yuzhen Ke, et al.
Journal of Diabetes Research|February 3, 2022
Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 DiabetesFeihui Zeng, Lingning Huang, Yongze Zhang, et al.
Pageof 5